Personal information

No personal information available

Activities

Collapse all

Employment (1)

National Institutes of Health: Bethesda, MD, US

2021-05-10 to present | Physician Scientist Early Investigator (Pediatric Oncology Branch)
Employment
Source: Self-asserted source
Anandani Nellan

Works (15)

Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis.

Journal of neuro-oncology
2022-06-22 | Journal article
DOI: 10.1007/s11060-022-04065-w
PMID: 35731362
Contributors: Greer HR; Miller K; Samay S; Nellan A; Green AL
Source: Self-asserted source
Anandani Nellan

Immunotherapy Associated Neurotoxicity in Pediatric Oncology.

Frontiers in oncology
2022-02-21 | Journal article
DOI: 10.3389/fonc.2022.836452
PMID: 35265526
PMC: PMC8899040
Contributors: Shalabi H; Nellan A; Shah NN; Gust J
Source: Self-asserted source
Anandani Nellan

Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma

Neuro-Oncology
2021-06-02 | Journal article
DOI: 10.1093/neuonc/noab135
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Source: Self-asserted source
Anandani Nellan

ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients

Journal of Neuropathology & Experimental Neurology
2020-12-04 | Journal article
DOI: 10.1093/jnen/nlaa091
Contributors: Anandani Nellan; Avery Bodlak; David M Mirsky; Jean Mulcahy Levy; Timothy P Garrington; Nicholas K Foreman; Ahmed Gilani; Masanori Hayashi
Source: check_circle
Crossref

Optimizing CARs for ocular delivery

Nature Cancer
2020-10 | Journal article
DOI: 10.1038/s43018-020-00127-y
Part of ISSN: 2662-1347
Source: Self-asserted source
Anandani Nellan

Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma

Journal of Neuro-Oncology
2020-07-06 | Journal article
DOI: 10.1007/s11060-020-03549-x
Contributors: Anandani Nellan; Erin Wright; Kristen Campbell; Kurtis D. Davies; Andrew M. Donson; Vladimir Amani; Alexis Judd; Molly S. Hemenway; Jennifer Raybin; Nicholas K. Foreman et al.
Source: check_circle
Crossref

Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas

Neuro-Oncology Advances
2020-01-01 | Journal article
DOI: 10.1093/noajnl/vdaa103
Part of ISSN: 2632-2498
Source: Self-asserted source
Anandani Nellan

Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.

Pediatric blood & cancer
2019-10-08 | Journal article
DOI: 10.1002/pbc.28028
PMID: 31595628
Source: Self-asserted source
Anandani Nellan

Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells.

Cell death & disease
2019-09-12 | Journal article
DOI: 10.1038/s41419-019-1880-y
PMID: 31515514
PMC: PMC6742667
Source: Self-asserted source
Anandani Nellan

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

Clinical Cancer Research
2019-04-15 | Journal article
DOI: 10.1158/1078-0432.CCR-18-0432
Contributors: Robbie G. Majzner; Johanna L. Theruvath; Anandani Nellan; Sabine Heitzeneder; Yongzhi Cui; Christopher W. Mount; Skyler P. Rietberg; Miles H. Linde; Peng Xu; Christopher Rota et al.
Source: check_circle
Crossref

Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques

Blood
2018-08-09 | Journal article
DOI: 10.1182/blood-2018-05-846428
Contributors: Anandani Nellan; Cynthia M. Lester McCully; Rafael Cruz Garcia; Nalini Jayaprakash; Brigitte C. Widemann; Daniel W. Lee; Katherine E. Warren
Source: check_circle
Crossref

Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells.

Journal for immunotherapy of cancer
2018-04-30 | Journal article
DOI: 10.1186/s40425-018-0340-z
PMID: 29712574
PMC: PMC5925833
Source: Self-asserted source
Anandani Nellan

Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.

Pediatric blood & cancer
2018-01-19 | Journal article
DOI: 10.1002/pbc.26960
PMID: 29350470
PMC: PMC5867234
Source: Self-asserted source
Anandani Nellan

Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up.

Pediatric neurology
2015-12-19 | Journal article
DOI: 10.1016/j.pediatrneurol.2015.12.005
PMID: 26810774
PMC: PMC4789174
Source: Self-asserted source
Anandani Nellan

Paving the road ahead for CD19 CAR T-cell therapy.

Current opinion in hematology
2015-11-01 | Journal article
DOI: 10.1097/MOH.0000000000000182
PMID: 26335422
PMC: PMC4718736
Source: Self-asserted source
Anandani Nellan

Peer review (2 reviews for 2 publications/grants)

Review activity for BioDrugs. (1)
Review activity for Nature communications (1)
How many people are using ORCID?